Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation

Clostridium difficile is currently the leading cause of nosocomial infection. Antibiotics remain the first-line therapy for C. difficile-associated diseases (CDAD), despite the risks of resistance promotion and further gut microbiota perturbation. Notably, the abundance of Bacteroides fragilis was r...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Huimin, Yang, Siqi, Zhang, Yucheng, Qian, Kai, Zhang, Zhaohui, Liu, Yangyang, Wang, Ye, Bai, Yang, Fan, Hongying, Zhao, Xinmei, Zhi, Fachao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308121/
https://www.ncbi.nlm.nih.gov/pubmed/30619112
http://dx.doi.org/10.3389/fmicb.2018.02976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308121/
https://www.ncbi.nlm.nih.gov/pubmed/30619112
http://dx.doi.org/10.3389/fmicb.2018.02976

Ejemplares similares